ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

GAO Report To Include Some But Not all Of Obey’s Charges

June 24, 1977

UCLA, NYU, Ohio States Must Wait Longer For Comprehensive Status

November 28, 1975

‘Be Careful We’re Not Fighting Old Battles’ On Study Section Issue

September 20, 1991

Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume

June 17, 1994

NCI to Support Research and Development Of Image Guided Therapy for Prostate Cancer

July 16, 1999

In Brief: Brinkley Asks Subcommittee to Add $62.5 Million To NCI Budget for Unfunded Grants

May 11, 1979